Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency

Genes and Immunity

Volumn 1, Issue 2, 1999, Pages 137-148

  Mullighan, C G ^a,b   Marshall, S E ^a   Bunce, M ^a   Welsh, K I ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Common variable immunodeficiency; Immunogenetics; Interleukin 10; Polymerase chain reaction and sequence specific primers; Tumour necrosis factor

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HLA ANTIGEN; LEUKOCYTE ANTIGEN; PRIMER DNA;

ARTICLE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; COHORT STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; DNA PRIMERS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; IMMUNOCONJUGATES; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, CCR5;

EID: 0033224451     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363653     Document Type: Article

References (43)

1. Ravine D, Cooper DN. Adult-onset genetic disease: mechanisms, analysis and prediction. Q J Med 1997; 90: 83-103.
2. Schork NJ. Genetics of complex disease: approaches, problems, and solutions. Am J Respirat Crit Care Med 1997; 156: S103-S109.
3. Kerem B, Rommens JM, Buchanan JA et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
4. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
5. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
6. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
7. Cunningham Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immnnol 1989; 9: 22-33.
8. Vorechovsky I, Zetterquist H, Paganelli R et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995; 77: 185-192.
9. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. Tumour necrosis factor and lymphotoxin-a polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997; 159: 6236-6241.
10. Jaffe JS, Strober W, Sneller MC. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood 1993; 82: 192-201.
11. Mullighan CG, Welsh KI, Bird AG. HLA associations of common variable immunodeficiency. Immunology 1995; 86: 56.
12. Sneller MC, Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 1990; 144: 3762-3769.
13. Fischer MB, Hauber I, Vogel E et al. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol 1993; 92: 340-352.
14. Bunce M, O'Neill CM, Barnardo MCNM et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-367.
15. Fanning GC, Bunce M, Black CM, Welsh KI. PCR-haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumour necrosis factor and lymphotoxin alpha. Tissue Antigens 1997; 50: 23-31.
16. Bell J. The new genetics in clinical practice. BMJ 1998; 316: 618-620.
17. Turner DM, Williams DM, Sankaran D et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
18. Aukrust P, Lien E, Kristoffersen AK et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 1996; 87: 674-681.
19. Joyce DA, Steer JH. IL-4, IL-10 and IFN-γ have distinct, but interacting, effects on differentiation-induced changes in TNF-α and TNF receptor release by cultured human monocytes. Cytokine 1996; 8: 49-57.
20. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986; 98: 311-322.
21. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1a,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol 1986; 136: 2734-2740.
22. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
23. Lo YD, Patel P, Newton CR et al. Direct haplotype determination by double ARMS: specificity, sensitivity and genetic applications. Nucleic Acids Res 1991; 19: 3561-3567.
24. Mullighan CG, Bunce M, Fanning GC et al. A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population. Gut 1997; 44: 566-569.
25. Olerup O, Zetterquist H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 1991; 37: 197-204.
26. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
27. WHO. Primary immunodeficiency diseases: report of a WHO scientific group. Clin Exp Immunol 1997; 109: 1-28.
28. Bunce M, Barnardo MCNM, Procter J et al. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibrium in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 1996; 48: 680-691.
29. Altman DG. Practical Statistics for Medical Research. Chapman & Hall: London, 1991.
30. McDowell TL, Symons JA, Ploski R et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995; 38: 221-228.
31. Pociot F, Molvig J, Wogensen L et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
32. Borish L, Mascali JJ, Klinnert M et al. SSC polymorphisms in interleukin genes. Hum Mol Genet 1994; 3: 1710.
33. Cambien F, Ricard S, Troesch A et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881-887.
34. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-725.
35. Gross C, Eccleshall T, Malloy PJ et al. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Mineral Res 1996; 11: 1850-1855.
36. Saijo T, Ito M, Takeda E et al. A unique mutation in the vitamin receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformational polymorphism analysis for heterozygous carrier detection. Am J Hum Genet 1991; 49: 668-673.
37. Faraco JH, Morrison NA, Baker A et al. ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res 1989; 17: 2150.
38. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-6669.
39. Clark MR, Clarkson SB, Ory PA et al. Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J Immunol 1989; 143: 1731-1734.
40. Wenzel K, Ernst M, Rohde K et al. DNA polymorphisms in adhesion molecule genes - a new risk factor for early atherosclerosis. Hum Genet 1996; 97: 15-20.
41. Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW. Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 1994; 21: 473-477.
42. Deichmann K, Heinzmann A, Brüggenolte E et al. An MseI RFLP in the human CTLA4 promoter. Biochem Biophys Res Comm 1996; 225: 817-818.
43. Dariavach P, Mattei MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988; 18: 1901-1905.